Inventor · disambiguated record

Charles David Pauza

Also filed as: PAUZA CHARLES DAVID

32 granted patents·23 pending applications·272 citations·filing 2016–2025

97Inventor score

Technology areasC12N A61K A61P C07K C12Y

Files withAMERICAN GENE TECH INT INC52 AMERICAN GENE TECH INTEMATIONAL INC1 TRAWSFYNYDD THERAPEUTICS INC1 VIRIOM INC1

Top patents by PatentIndex Score

55 records

0197US10233464B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Mar 19, 2019·25 cites·14 claims
0297US10137144B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 27, 2018·28 cites·20 claims
0397US10036040B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·30 cites·19 claims
0497US10036038B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·25 cites·18 claims
0597US9914938B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Mar 13, 2018·34 cites·17 claims
0697US9834790B1Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Dec 5, 2017·33 cites·13 claims
0796US10420789B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Sep 24, 2019·13 cites·20 claims
0896US10023880B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 17, 2018·29 cites·11 claims
0995US10472649B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 12, 2019·14 cites·6 claims
1094US11090379B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2019·Granted Aug 17, 2021·5 cites·39 claims
1194US10772905B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Sep 15, 2020·6 cites·14 claims
1293US10888613B2Method of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2017·Granted Jan 12, 2021·5 cites·12 claims
1393US10767183B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2017·Granted Sep 8, 2020·7 cites·24 claims
1493US10494647B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Dec 3, 2019·5 cites·17 claims
1592US10428350B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Oct 1, 2019·7 cites·16 claims
1691US2025121051A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
1789US12370253B2Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Granted Jul 29, 2025·0 cites·10 claims
1888US11612649B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2021·Granted Mar 28, 2023·1 cites·94 claims
1988US11519006B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Dec 6, 2022·1 cites·16 claims
2088US11242527B1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2021·Granted Feb 8, 2022·1 cites·19 claims
2186US11534450B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
2285US12410446B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·13 claims
2385US2024238406A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
2484US12403155B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 2, 2025·0 cites·16 claims
2584US2025121050A1Methods of producing cells resistant to hiv infectionAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
2684US2025042975A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
2784US2023241200A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
2883US2025376685A1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
2982US11911458B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 27, 2024·1 cites·18 claims
3080US2024252615A1Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
3179US12359203B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2022·Granted Jul 15, 2025·0 cites·26 claims
3279US11980663B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2016·Granted May 14, 2024·1 cites·18 claims
3378US2024091340A1Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3477US2024141381A1Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3574US12410445B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·17 claims
3674US2024115604A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3774US2024141374A1On demand expression of exogenous factors in lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3874US2025179150A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
3973US10975374B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2020·Granted Apr 13, 2021·0 cites·18 claims
4073US2023285480A1Viral vectors for treating parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
4172US12090200B2Methods of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2020·Granted Sep 17, 2024·0 cites·12 claims
4268US11352646B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
4365US11820999B2Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 21, 2023·0 cites·6 claims
4464US2025376464A1Compounds for treatment a coronavirus infectionTRAWSFYNYDD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4563US11976292B2Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2016·Granted May 7, 2024·0 cites·12 claims
4663US2024279678A1On demand expression of exogenous factors in lymphocytes to treat hivAMERICAN GENE TECH INT INC·Filed 2021·Application pending·0 cites
4762US2021015868A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2019·Application pending·0 cites
4861US11583562B2Viral vectors for treating Parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 21, 2023·0 cites·4 claims
4959US2024075140A1Engineered nk cells and methods of treating cancerAMERICAN GENE TECH INTEMATIONAL INC·Filed 2022·Application pending·0 cites
5058US2025332162A1Inhibiting purine biosynthesis to increase favipiravir potency against rna virus infectionsVIRIOM INC·Filed 2023·Application pending·0 cites

Showing the top 50 of 55 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Charles David Pauza files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →